BBIO BridgeBio Pharma, Inc. - Common Stock
$84,70
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 10, 2026
52W-Spanne
$47–$93
81% of range
Analystenbewertung
BUY
28 analysts
Kursziel
$108
+28% upside
P/E (TTM)
-22.5
ROE
41.2%
Nettogewinnmarge
-146.0%
BBIO Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$84.70
Marktkapitalisierung
$16.58B
P/E (TTM)
-22.5
EPS (TTM)
$-3.78
Umsatz (TTM)
$502M
Dividendenrendite
—
ROE
41.2%
Verschuldungsgrad
—
52W-Spanne
$47 – $93
BBIO Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$502M
2019-12-31
→
2025-12-31
EPS
$-3.78
2020-12-31
→
2025-12-31
Freier Cashflow
$-447M
2019-12-31
→
2025-12-31
Margen
-146.0%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
BBIO
Peer-Median
P/E (TTM)
-22.5
28.5
P/S (TTM) (K/V (TTM))
33.0
20.1
P/B (K/B)
-7.9
12.9
Price / FCF (Kurs / FCF)
-37.1
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
BBIO
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-104.2%
—
Net Profit Margin (Nettogewinnmarge)
-146.0%
-48.4%
ROA
-79.0%
-28.4%
ROE
41.2%
-49.2%
ROIC
25.1%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
BBIO
Peer-Median
Current Ratio (Liquiditätsgrad)
2.8
5.0
Quick Ratio
2.5
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
BBIO
Peer-Median
Revenue YoY (Umsatz YoY)
126.3%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
86.3%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
127.4%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
BBIO
Peer-Median
BBIO Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
28 Analysten
- Starker Kauf 6 21,4%
- Kauf 19 67,9%
- Halten 3 10,7%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
21 Analysten · 2026-08-16
Median
$108.00
Jetzt
$84.70
Tief
$80.00
Hoch
$157.00
Median-Ziel
$108.00
+27,5%
Mittelwert-Ziel
$108.43
+28,0%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.11%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.78 | $-0.60 | -0.18% |
| 31. März 2026 | $-0.84 | $-0.69 | -0.15% |
| 31. Dezember 2025 | $-1.00 | $-0.76 | -0.24% |
| 30. September 2025 | $-0.95 | $-0.91 | -0.04% |
| 30. Juni 2025 | $-0.95 | $-0.86 | -0.09% |
| 31. März 2025 | $-0.88 | $-0.94 | 0.06% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| BBIO | $14.90B | -20.2 | 126.3% | -146.0% | 41.2% | — |
| MRNA | $11.62B | -4.1 | -39.9% | -145.2% | -31.3% | — |
| INCY | $19.60B | 15.4 | 21.2% | 25.0% | 27.6% | — |
| UTHR | $21.27B | 17.5 | 10.6% | 41.9% | 18.7% | 87.9% |
| NBIX | $14.20B | 30.4 | 21.4% | 16.7% | 16.1% | — |
| BMRN | $11.43B | 33.0 | 12.9% | 10.8% | 5.8% | — |
| EXEL | $11.44B | 15.7 | 7.0% | 33.7% | 37.3% | — |
| ARWR | $4.68B | -3449.0 | 23258.2% | -0.20% | -0.50% | — |
| MDGL | $13.30B | -45.3 | 432.1% | -30.1% | -44.4% | — |
| HALO | $7.93B | 26.3 | 37.5% | 22.7% | 166.1% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $502M | $222M | $9M | $78M | $70M | $8M | $41M | |
| Cost of Revenue | $21M | $4M | $2M | $3M | $3M | · | · | |
| R&D Expense | $452M | $506M | $456M | $399M | $451M | $337M | $210M | |
| SG&A Expense | $531M | $289M | $151M | $143M | $192M | $146M | $94M | |
| Operating Expenses | $1.03B | $815M | $617M | $590M | $646M | $483M | $307M | |
| Operating Income | $-523M | $-593M | $-607M | $-512M | $-577M | $-474M | $-266M | |
| Interest Expense | · | · | $81M | $80M | $47M | $37M | $9M | |
| Interest Income | $20M | $17M | $18M | $8M | $1M | $4M | $9M | |
| Other Non-op | $43M | $12M | $17M | $-8M | $36M | $2M | $-2M | |
| Pretax Income | $-733M | $-542M | $-653M | $-485M | · | $505M | $289M | |
| Income Tax | $435.0K | $1M | $0 | $0 | · | · | · | |
| Net Income | $-733M | $-543M | $-653M | $-485M | $-586M | $-505M | $-289M | |
| EPS (Basic) | $-3.78 | $-2.88 | $-3.95 | $-3.26 | $-3.90 | $-3.80 | · | |
| EPS (Diluted) | $-3.78 | $-2.88 | $-3.95 | $-3.26 | $-3.90 | $-3.80 | · | |
| Shares (Basic) | 191,527,482 | 186,075,873 | 162,791,511 | 147,473,076 | 144,356,619 | 117,995,457 | · | |
| Shares (Diluted) | 191,527,482 | 186,075,873 | 162,791,511 | 147,473,076 | 144,356,619 | 117,995,457 | · | |
| EBITDA | $-518M | $-587M | $-601M | $-505M | $-571M | $-474M | $-266M |
Bilanz 26
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $570M | $681M | $376M | $377M | $394M | $356M | $364M | |
| Short-term Investments | · | $0 | $0 | $52M | $394M | $251M | $182M | |
| Receivables | $139M | $5M | $2M | · | · | · | · | |
| Inventory | $27M | $0 | · | · | · | · | · | |
| Prepaid Expense | $44M | $35M | $24M | $22M | $32M | $36M | $20M | |
| Current Assets | $798M | $721M | $478M | $549M | $889M | $643M | $569M | |
| PP&E (Net) | $5M | $7M | $12M | $15M | $30M | $20M | $6M | |
| Intangibles | $28M | $24M | $26M | $29M | $45M | $0 | · | |
| Other Non-current Assets | $17M | $18M | $23M | $20M | $33M | $24M | $26M | |
| Total Assets | $936M | $919M | $546M | $623M | $1.01B | $704M | $632M | |
| Accounts Payable | $36M | $10M | $11M | $12M | $12M | $9M | $9M | |
| Accrued Liabilities | · | · | · | · | · | · | $3M | |
| Current Liabilities | $288M | $154M | $144M | $121M | $135M | $96M | $60M | |
| Capital Leases | $4M | $5M | $9M | $12M | $17M | $15M | · | |
| Other Non-current Liabilities | $244.0K | $286.0K | $6M | $27M | $22M | $10M | $4M | |
| Total Liabilities | $3.01B | $2.38B | $1.89B | $1.87B | $1.88B | $596M | $156M | |
| Long-term Debt | $2.01B | · | · | · | · | $94M | $95M | |
| Total Debt | · | $437M | $446M | $431M | $431M | $94M | $92M | |
| Common Stock | $202.0K | $196.0K | $181.0K | $157.0K | $154.0K | $125.0K | $124.0K | |
| Paid-in Capital | $2.06B | $1.90B | · | · | · | · | · | |
| Retained Earnings | $-3.82B | $-3.10B | $-2.56B | $-1.92B | $-1.44B | $-889M | $-440M | |
| Treasury Stock | $323M | $275M | $275M | $275M | $275M | $75M | · | |
| AOCI | $12.0K | $8.0K | $31.0K | $-328.0K | $-132.0K | $192.0K | $254.0K | |
| Stockholders' Equity | $-2.09B | $-1.47B | $-1.35B | $-1.25B | $-870M | $58M | $408M | |
| Liabilities + Equity | $936M | $919M | $546M | $623M | $1.01B | $704M | $632M | |
| Shares Outstanding | 194,771,957 | 190,044,473 | 175,082,951 | 150,625,572 | 147,343,323 | 122,849,389 | 123,658,287 |
Cashflow 18
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $5M | $6M | $6M | $7M | $6M | $1M | $859.0K | |
| Stock-based Comp | $133M | $96M | $109M | $92M | $100M | $58M | $21M | |
| Deferred Tax | $0 | $0 | $0 | · | · | · | · | |
| Amort. of Intangibles | $3M | $2M | $2M | $2M | $3M | · | · | |
| Restructuring | · | $16M | $8M | $44M | $0 | $0 | · | |
| Other Non-cash | $149M | $-79M | $10M | $-33M | $-17M | · | · | |
| Operating Cash Flow | $-446M | $-521M | $-528M | $-419M | $-498M | $-400M | $-254M | |
| CapEx | $1M | $933.0K | $1M | $5M | $13M | $8M | $3M | |
| Investing Cash Flow | $-24M | $61M | $54M | $453M | $-201M | $-53M | $-217M | |
| Net Debt Issued | · | $-473M | $0 | $-20M | $-124M | · | · | |
| Stock Issued | $0 | $315M | $450M | $5M | $0 | $0 | · | |
| Stock Repurchased | $48M | $0 | $0 | $0 | $200M | $75M | · | |
| Net Stock Activity | $-48M | $315M | $144M | $5M | $-200M | $-75M | · | |
| Dividends Paid | · | · | · | · | · | · | $997.0K | |
| Financing Cash Flow | $359M | $748M | $452M | $-13M | $736M | $447M | $399M | |
| Net Change in Cash | $-111M | $289M | $-22M | $21M | $38M | $-6M | $-72M | |
| Taxes Paid | $1M | $0 | $0 | · | · | · | · | |
| Free Cash Flow | $-447M | $-522M | $-529M | $-424M | $-511M | $-407M | $-256M |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -104.2% | -267.2% | -6528.7% | -659.6% | -827.1% | -5752.0% | -656.4% | |
| Net Margin | -146.0% | -244.9% | -7021.9% | -624.2% | -841.2% | -6127.9% | -711.5% | |
| Pretax Margin | -145.9% | -244.3% | · | · | · | 6127.9% | 711.5% | |
| EBITDA Margin | -103.2% | -264.5% | -6458.9% | -650.9% | -818.7% | -5752.0% | -656.4% | |
| ROA | -79.0% | -74.1% | -111.7% | -59.2% | -68.3% | -75.7% | -52.6% | |
| ROE | 41.2% | 38.5% | 50.1% | 45.6% | 144.4% | -216.8% | -101.0% | |
| ROIC | 25.1% | 57.7% | · | · | · | · | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.8 | 4.7 | 3.3 | 4.5 | 6.6 | 6.7 | 9.4 | |
| Quick Ratio | 2.5 | 4.4 | 2.6 | 3.5 | 5.8 | 6.3 | 9.0 | |
| Debt / Equity | · | -0.3 | -0.3 | -0.3 | -0.5 | 1.6 | 0.2 | |
| LT Debt / Equity | · | -0.3 | -0.3 | -0.3 | -0.5 | 1.6 | 0.2 | |
| Interest Coverage | · | · | -7.5 | -6.4 | -12.3 | -12.9 | -30.4 |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.3 | 0.0 | 0.1 | 0.1 | 0.0 | 0.1 | |
| Inventory Turnover | 1.6 | · | · | · | · | · | · | |
| Receivables Turnover | 7.0 | 68.6 | · | · | · | · | · |
Wachstumsraten 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 126.3% | 2285.3% | -88.0% | 11.4% | 745.1% | · | · | |
| Revenue CAGR 3Y | 86.3% | 47.1% | 4.1% | · | · | · | · | |
| Revenue CAGR 5Y | 127.4% | · | · | · | · | · | · |
Bewertung (TTM) 17
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $502M | $222M | $9M | $78M | $70M | $8M | $41M | |
| Net Income TTM | $-733M | $-543M | $-653M | $-485M | $-586M | $-505M | $-289M | |
| Market Cap | $14.90B | $5.21B | $7.07B | $1.15B | $2.46B | $8.74B | $4.33B | |
| Enterprise Value | · | $4.97B | $7.14B | $1.15B | $2.10B | $8.22B | $3.88B | |
| P/E | -20.2 | -9.5 | -10.2 | -2.3 | -4.3 | -18.7 | · | |
| P/S | 29.7 | 23.5 | 759.8 | 14.8 | 35.3 | 1059.0 | 106.9 | |
| P/B | -7.1 | -3.6 | -5.2 | -0.9 | -2.8 | 150.9 | 10.6 | |
| P / Tangible Book | · | · | · | · | · | 150.9 | · | |
| P / Cash Flow | -33.4 | -10.0 | -13.4 | -2.7 | -4.9 | -21.9 | -17.1 | |
| P / FCF | -33.3 | -10.0 | -13.4 | -2.7 | -4.8 | -21.5 | -16.9 | |
| EV / EBITDA | · | -8.5 | -11.9 | -2.3 | -3.7 | -17.3 | -14.6 | |
| EV / FCF | · | -9.5 | -13.5 | -2.7 | -4.1 | -20.2 | -15.1 | |
| EV / Revenue | · | 22.4 | 767.3 | 14.8 | 30.1 | 996.8 | 95.7 | |
| Dividend Yield | · | · | · | · | · | · | 0.02% | |
| Earnings Yield | -4.9% | -10.5% | -9.8% | -42.8% | -23.4% | -5.3% | · | |
| Payout Ratio | · | · | · | · | · | · | -0.35% | |
| Annual Payout | · | · | · | · | · | · | $997.0K |
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $244M | $195M | $154M | $121M | $111M | $117M | $6M | $3M | $2M | $211M | $2M | $4M | $2M | $2M | $2M | $338.0K | |
| Cost of Revenue | $15M | $10M | $8M | $7M | $4M | $3M | $2M | $598.0K | $598.0K | $598.0K | $598.0K | $598.0K | $599.0K | $651.0K | $647.0K | $739.0K | |
| R&D Expense | $149M | $127M | $116M | $113M | $111M | $111M | $130M | $120M | $115M | $141M | $130M | $125M | $107M | $93M | $91M | $93M | |
| SG&A Expense | $186M | $164M | $158M | $138M | $129M | $106M | $95M | $69M | $60M | $66M | $48M | $36M | $36M | $31M | $32M | $31M | |
| Operating Expenses | $351M | $300M | $294M | $266M | $245M | $221M | $232M | $194M | $178M | $211M | $179M | $162M | $148M | $128M | $131M | $129M | |
| Operating Income | $-107M | $-106M | $-140M | $-145M | $-134M | $-104M | $-226M | $-192M | $-176M | $343.0K | $-177M | $-158M | $-146M | $-126M | $-129M | $-129M | |
| Interest Expense | · | · | · | · | · | · | · | · | $23M | $23M | · | $20M | $21M | $20M | · | $20M | |
| Interest Income | $7M | $6M | $4M | $6M | $4M | $5M | $5M | $3M | $5M | $4M | $6M | $4M | $5M | $4M | $4M | $2M | |
| Other Non-op | $6M | $4M | $12M | $16M | $7M | $8M | $2M | $2M | $-632.0K | $9M | $22M | $-5M | $1M | $-601.0K | $5M | $6M | |
| Pretax Income | $-156M | · | $-195M | $-186M | $-182M | · | $-266M | $-164M | $-76M | · | · | · | · | · | · | · | |
| Income Tax | $0 | · | $-120.0K | $-2M | $2M | $0 | $1M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-156M | $-167M | $-195M | $-185M | $-184M | $-170M | $-267M | $-164M | $-76M | $-36M | $-170M | $-179M | $-161M | $-143M | $-141M | $-140M | |
| EPS (Basic) | $-0.78 | $-0.84 | $-1.00 | $-0.95 | $-0.95 | $-0.88 | $-1.43 | $-0.86 | $-0.39 | $-0.20 | $-0.97 | $-1.08 | $-0.98 | $-0.92 | $-0.91 | $-0.93 | |
| EPS (Diluted) | $-0.78 | $-0.84 | $-1.00 | $-0.95 | $-0.95 | $-0.88 | $-1.43 | $-0.86 | $-0.39 | $-0.20 | $-0.97 | $-1.08 | $-0.98 | $-0.92 | $-0.91 | $-0.93 | |
| Shares (Basic) | 195,785,884 | 194,789,897 | -380,989,138 | 191,854,152 | 190,517,215 | 190,145,253 | -368,726,489 | 188,510,372 | 187,586,680 | 178,705,310 | -313,698,191 | 163,308,632 | 160,535,435 | 152,645,635 | -293,031,694 | 147,937,817 | |
| Shares (Diluted) | 195,785,884 | 194,789,897 | -380,989,138 | 191,854,152 | 190,517,215 | 190,145,253 | -368,726,489 | 188,510,372 | 187,586,680 | 178,705,310 | -313,698,191 | 163,308,632 | 160,535,435 | 152,645,635 | -293,031,694 | 147,937,817 | |
| EBITDA | $-107M | $-105M | · | $-145M | $-134M | $-103M | · | $-192M | $-176M | $2M | · | $-158M | $-146M | $-125M | · | $-129M |
Bilanz 25
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $678M | $880M | $570M | $643M | $749M | $541M | $681M | $266M | $408M | $475M | $376M | $505M | $302M | $407M | $377M | $483M | |
| Short-term Investments | · | · | · | · | $8M | · | · | · | $40M | $44M | · | $0 | $31M | $34M | · | $75M | |
| Receivables | $254M | $205M | $139M | $117M | $77M | $115M | $5M | · | · | · | · | · | · | · | · | · | |
| Inventory | $53M | $33M | $27M | $25M | $18M | $4M | $0 | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $66M | $63M | $44M | $52M | $60M | $35M | $35M | $38M | $28M | $28M | · | $23M | $21M | $25M | · | $26M | |
| Current Assets | $1.09B | $1.24B | $798M | $839M | $912M | $695M | $721M | $445M | $616M | $783M | · | $588M | $433M | $553M | · | $642M | |
| PP&E (Net) | $5M | $5M | $5M | $6M | $6M | $7M | $7M | $9M | $10M | $11M | · | $12M | $13M | $14M | · | $16M | |
| Intangibles | $27M | $27M | $28M | $29M | $30M | $28M | $24M | $25M | $25M | $26M | · | $27M | $28M | $28M | · | $29M | |
| Other Non-current Assets | $20M | $19M | $17M | $26M | $18M | $17M | $18M | $20M | $19M | $21M | · | $19M | $20M | $21M | · | $30M | |
| Total Assets | $1.22B | $1.37B | $936M | $998M | $1.08B | $882M | $919M | $665M | $794M | $849M | · | $655M | $504M | $626M | · | $729M | |
| Accounts Payable | $27M | $29M | $36M | $19M | $26M | $28M | $10M | $13M | $18M | $5M | · | $4M | $4M | $4M | · | $10M | |
| Current Liabilities | $891M | $816M | $288M | $217M | $176M | $152M | $154M | $139M | $134M | $141M | · | $106M | $110M | $97M | · | $119M | |
| Capital Leases | $15M | $14M | $4M | $3M | $4M | $5M | $5M | $6M | $7M | $8M | · | $10M | $11M | $12M | · | $13M | |
| Other Non-current Liabilities | $240.0K | $229.0K | $244.0K | $679.0K | $545.0K | $352.0K | $286.0K | $377.0K | $485.0K | $595.0K | · | $12M | $13M | $18M | · | $28M | |
| Total Liabilities | $3.72B | $3.64B | $3.01B | $2.92B | $2.86B | $2.52B | $2.38B | $1.88B | $1.88B | $1.89B | · | $1.85B | $1.85B | $1.84B | · | $1.86B | |
| Long-term Debt | $2.65B | $2.65B | $2.01B | $2.01B | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | · | · | · | · | $0 | $0 | · | $436M | $435M | $435M | · | $442M | $440M | $436M | · | · | |
| Common Stock | $206.0K | $204.0K | $202.0K | $200.0K | $198.0K | $197.0K | $196.0K | $195.0K | $194.0K | $193.0K | · | $180.0K | $168.0K | $167.0K | · | $156.0K | |
| Paid-in Capital | $2.16B | $2.11B | $2.06B | $2.02B | · | · | $1.90B | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-4.14B | $-3.99B | $-3.82B | $-3.63B | $-3.45B | $-3.26B | $-3.10B | $-2.83B | $-2.67B | $-2.60B | · | $-2.39B | $-2.22B | $-2.06B | · | $-1.78B | |
| Treasury Stock | $533M | $406M | $323M | $323M | $323M | $323M | $275M | $275M | $275M | $275M | · | $275M | $275M | $275M | · | $275M | |
| AOCI | $-7.0K | $-8.0K | $12.0K | $2.0K | $1.0K | $0 | $8.0K | $5.0K | $-4.0K | $2.0K | · | $34.0K | $63.0K | $-12.0K | · | $-348.0K | |
| Stockholders' Equity | $-2.52B | $-2.28B | $-2.09B | $-1.93B | $-1.79B | $-1.65B | $-1.47B | $-1.23B | $-1.09B | $-1.05B | · | $-1.21B | $-1.36B | $-1.23B | · | $-1.14B | |
| Liabilities + Equity | $1.22B | $1.37B | $936M | $998M | $1.08B | $882M | $919M | $665M | $794M | $849M | · | $655M | $504M | $626M | · | $729M | |
| Shares Outstanding | 195,284,352 | 195,707,702 | 194,771,957 | 192,633,286 | 191,162,659 | 189,826,023 | 190,044,473 | 188,986,547 | 188,032,738 | 187,122,744 | 175,082,951 | 174,131,954 | 161,419,931 | 160,435,238 | · | 149,367,087 |
Cashflow 16
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Stock-based Comp | $44M | $33M | $35M | $35M | $37M | $26M | $30M | $27M | $21M | $17M | $37M | $23M | $27M | $22M | $22M | $17M | |
| Amort. of Intangibles | $700.0K | $700.0K | $700.0K | $700.0K | $700.0K | $600.0K | $600.0K | $600.0K | $600.0K | $600.0K | $600.0K | $600.0K | $600.0K | $600.0K | $300.0K | $600.0K | |
| Restructuring | · | · | · | · | · | · | · | $5M | $3M | $3M | · | $272.0K | $4M | $3M | $8M | $5M | |
| Other Non-cash | · | $-65M | · | · | · | $-57M | · | · | · | $-202M | · | · | · | $-25M | · | · | |
| Operating Cash Flow | $-71M | $-197M | $-56M | $-110M | $-81M | $-199M | $-195M | $-181M | $75M | $-220M | $-125M | $-145M | $-113M | $-144M | $-93M | $-135M | |
| CapEx | $443.0K | $69.0K | $33.0K | $470.0K | $594.0K | $0 | $47.0K | $137.0K | $54.0K | $695.0K | $435.0K | $431.0K | $428.0K | $12.0K | $801.0K | $759.0K | |
| Investing Cash Flow | $18M | $-43M | $-14M | $4M | $-13M | $-2M | $-3M | $38M | $3M | $23M | $-66.0K | $38M | $4M | $12M | $18M | $147M | |
| Debt Issued | · | · | · | · | · | · | · | $0 | $0 | $450M | · | $0 | $0 | $0 | · | · | |
| Net Debt Issued | · | · | · | · | · | $-459M | · | · | · | $-23M | · | · | · | · | · | · | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $0 | $-18.0K | $-495.0K | $315M | $-454.0K | $306M | $1M | $143M | $5M | $0 | |
| Stock Repurchased | $128M | $82M | $0 | $0 | $0 | $48M | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | · | $-82M | · | · | · | $-48M | · | · | · | $315M | · | · | · | $143M | · | · | |
| Financing Cash Flow | $-149M | $550M | $-2M | $-894.0K | $302M | $60M | $474M | $707.0K | $-6M | $280M | $-5M | $307M | $-1M | $150M | $6M | $1M | |
| Net Change in Cash | $-202M | $310M | $-73M | $-106M | $208M | $-141M | $275M | $-142M | $72M | $83M | $-129M | $199M | $-110M | $18M | $-69M | $13M | |
| Free Cash Flow | · | $-197M | · | · | · | $-199M | · | · | · | $-220M | · | · | · | $-144M | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -43.9% | -54.5% | · | -120.3% | -121.4% | -89.5% | · | -7018.7% | -8096.8% | 0.16% | · | -3854.6% | -8903.1% | -6909.3% | · | -38200.0% | |
| Net Margin | -64.0% | -85.6% | · | -153.2% | -166.2% | -145.4% | · | -6012.2% | -3484.5% | -17.1% | · | -4387.4% | -9793.0% | -7816.6% | · | -41477.2% | |
| Pretax Margin | -64.0% | · | · | -154.5% | -164.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -43.9% | -53.9% | · | -120.3% | -121.4% | -88.4% | · | -7018.7% | -8096.8% | 0.92% | · | -3854.6% | -8903.1% | -6819.8% | · | -38200.0% | |
| ROA | -13.6% | -14.8% | · | -22.2% | -19.6% | -19.6% | · | -24.9% | -11.6% | -4.9% | · | -25.9% | -23.5% | -19.8% | · | -18.6% | |
| ROE | 7.2% | 8.5% | · | 11.7% | 12.8% | 12.6% | · | 13.5% | 6.2% | 3.2% | · | 15.3% | 13.5% | 12.6% | · | 14.9% | |
| ROIC | 4.3% | · | · | 7.4% | 7.6% | · | · | · | · | · | · | · | · | · | · | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.5 | · | 3.9 | 5.2 | 4.6 | · | 3.2 | 4.6 | 5.5 | · | 5.5 | 3.9 | 5.7 | · | 5.4 | |
| Quick Ratio | 1.0 | 1.3 | · | 3.5 | 4.7 | 4.3 | · | 1.9 | 3.3 | 3.7 | · | 4.8 | 3.0 | 4.6 | · | 4.7 | |
| Debt / Equity | · | · | · | · | 0.0 | 0.0 | · | -0.4 | -0.4 | -0.4 | · | -0.4 | -0.3 | -0.4 | · | · | |
| LT Debt / Equity | · | · | · | · | 0.0 | 0.0 | · | -0.4 | -0.4 | -0.4 | · | -0.4 | -0.3 | -0.4 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -7.7 | 0.0 | · | -7.8 | -7.1 | -6.3 | · | -6.5 |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.3 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.4 | 0.5 | · | 0.5 | 0.4 | 1.3 | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.5 | 1.2 | · | 2.1 | 2.8 | 2.0 | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $669M | $542M | · | $351M | $232M | $333M | · | $220M | $219M | $219M | · | $8M | $78M | $78M | · | $78M | |
| Net Income TTM | $-691M | $-705M | · | $-703M | $-593M | $-446M | · | $-455M | $-452M | $-519M | · | $-623M | $-446M | $-487M | · | $-505M | |
| Market Cap | $14.54B | $14.53B | · | $10.01B | $8.25B | $6.56B | · | $4.81B | $4.76B | $5.79B | · | $4.59B | $2.78B | $2.66B | · | $1.48B | |
| Enterprise Value | · | · | · | · | $7.50B | $6.02B | · | $4.98B | $4.75B | $5.70B | · | $4.53B | $2.88B | $2.65B | · | · | |
| P/E | -21.2 | -20.5 | · | -14.3 | -14.0 | -14.8 | · | -10.1 | -9.6 | -9.7 | · | -6.7 | -5.9 | -5.1 | · | -2.9 | |
| P/S | 21.7 | 26.8 | · | 28.5 | 35.6 | 19.7 | · | 21.9 | 21.7 | 26.5 | · | 581.5 | 35.8 | 34.3 | · | 19.0 | |
| P/B | -5.8 | -6.4 | · | -5.2 | -4.6 | -4.0 | · | -3.9 | -4.4 | -5.5 | · | -3.8 | -2.0 | -2.2 | · | -1.3 | |
| P / Cash Flow | · | -73.7 | · | · | · | -32.9 | · | · | · | -26.4 | · | · | · | -18.4 | · | · | |
| P / FCF | · | -73.6 | · | · | · | -32.9 | · | · | · | -26.3 | · | · | · | -18.4 | · | · | |
| EV / EBITDA | · | · | · | · | -55.8 | -58.4 | · | -26.0 | -27.1 | 2940.1 | · | -28.7 | -19.7 | -21.3 | · | · | |
| EV / FCF | · | · | · | · | · | -30.2 | · | · | · | -25.9 | · | · | · | -18.4 | · | · | |
| EV / Revenue | · | · | · | · | 32.3 | 18.1 | · | 22.6 | 21.7 | 26.1 | · | 573.5 | 37.2 | 34.2 | · | · | |
| Earnings Yield | -4.7% | -4.9% | · | -7.0% | -7.1% | -6.7% | · | -9.9% | -10.5% | -10.3% | · | -14.8% | -16.9% | -19.7% | · | -34.3% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $502M | $222M | $9M | $78M | $70M |
| Betriebsgewinnmarge % | -104.2% | -267.2% | -6528.7% | -659.6% | -827.1% |
| Nettoergebnis | $-733M | $-543M | $-653M | $-485M | $-586M |
| Verwässerte EPS | $-3.78 | $-2.88 | $-3.95 | $-3.26 | $-3.90 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | — | -0.3 | -0.3 | -0.3 | -0.5 |
| Liquiditätsgrad | 2.8 | 4.7 | 3.3 | 4.5 | 6.6 |
| Quick Ratio | 2.5 | 4.4 | 2.6 | 3.5 | 5.8 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-447M | $-522M | $-529M | $-424M | $-511M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 532 Einreicher · $11.5B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 98 (+4 vs. Vorquartal) | 65 (+9 vs. Vorquartal) | 176 (0 vs. Vorquartal) | 161 (+14 vs. Vorquartal) | +32.3M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. | $987.677.120 | 13.260.971 | 8,61% | Aktien |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $800.143.332 | 10.743.063 | 6,97% | Aktien |
| VIKING GLOBAL INVESTORS LP | $741.017.831 | 9.949.219 | 6,46% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $588.315.509 | 7.898.973 | 5,13% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $570.272.655 | 7.656.722 | 4,97% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $360.280.689 | 4.837.281 | 3,14% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $351.708.339 | 4.722.185 | 3,06% | Aktien |
| Aisling Capital Management LP | $341.834.227 | 4.589.611 | 2,98% | Aktien |
| STATE STREET CORP | $330.388.215 | 4.435.932 | 2,88% | Aktien |
| UBS Group AG | $287.753.480 | 3.863.500 | 2,51% | Kaufoption |
| JANE STREET GROUP, LLC | $232.407.392 | 3.120.400 | 2,02% | Kaufoption |
| CITADEL ADVISORS LLC | $231.388.431 | 3.106.719 | 2,02% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $221.507.973 | 2.973.184 | 1,93% | Aktien |
| D. E. Shaw & Co., Inc. | $218.406.046 | 2.932.412 | 1,90% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $195.152.496 | 2.620.200 | 1,70% | Kaufoption |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $167.728.960 | 2.252.000 | 1,46% | Aktien |
| Polar Capital Holdings Plc | $153.697.598 | 2.063.609 | 1,34% | Aktien |
| FMR LLC | $152.985.495 | 2.054.048 | 1,33% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $145.662.994 | 1.955.733 | 1,27% | Aktien |
| SC US (TTGP), LTD. | $138.559.911 | 1.860.364 | 1,21% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $127.311.718 | 1.709.341 | 1,11% | Aktien |
| NORGES BANK | $126.152.213 | 1.693.773 | 1,10% | Aktien |
| Frazier Life Sciences Management, L.P. | $115.305.393 | 1.548.139 | 1,00% | Aktien |
| Point72 Asset Management, L.P. | $113.640.243 | 1.525.782 | 0,99% | Aktien |
| JANE STREET GROUP, LLC | $112.904.828 | 1.515.908 | 0,98% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $107.937.207 | 1.453.504 | 0,94% | Aktien |
| Pictet Asset Management Holding SA | $107.362.071 | 1.448.126 | 0,94% | Aktien |
| TWO SIGMA ADVISERS, LP | $107.165.167 | 1.401.035 | 0,93% | Aktien |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $102.265.291 | 1.373.057 | 0,89% | Aktien |
| Laurion Capital Management LP | $100.714.388 | 1.352.234 | 0,88% | Aktien |
| Hood River Capital Management LLC | $100.364.407 | 1.347.535 | 0,87% | Aktien |
| Balyasny Asset Management L.P. | $91.614.273 | 1.230.052 | 0,80% | Aktien |
| Squarepoint Ops LLC | $88.760.199 | 1.191.732 | 0,77% | Aktien |
| VANGUARD GROUP INC | $88.444.087 | 1.156.283 | 0,77% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $86.057.320 | 1.155.442 | 0,75% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $83.193.341 | 1.116.989 | 0,72% | Aktien |
| AMERIPRISE FINANCIAL INC | $82.434.273 | 1.106.795 | 0,72% | Aktien |
| PRIMECAP MANAGEMENT CO/CA/ | $75.670.190 | 1.015.980 | 0,66% | Aktien |
| FIL Ltd | $74.648.325 | 1.002.260 | 0,65% | Aktien |
| Clearbridge Investments, LLC | $73.966.324 | 993.103 | 0,64% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $73.400.040 | 985.500 | 0,64% | Verkaufsoption |
| GOLDMAN SACHS GROUP INC | $66.118.056 | 887.729 | 0,58% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $63.817.890 | 856.846 | 0,56% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $61.804.000 | 829.802 | 0,54% | Aktien |
| Ensign Peak Advisors, Inc | $56.677.567 | 760.977 | 0,49% | Aktien |
| Qube Research & Technologies Ltd | $54.162.228 | 727.205 | 0,47% | Aktien |
| Capital Research Global Investors | $52.143.969 | 700.107 | 0,45% | Aktien |
| BARCLAYS PLC | $51.071.756 | 685.711 | 0,44% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48.652.124 | 653.224 | 0,42% | Aktien |
| First Turn Management, LLC | $47.172.951 | 633.364 | 0,41% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $46.288.968 | 621.494 | 0,40% | Aktien |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | $46.261.390 | 621.125 | 0,40% | Aktien |
| BANK OF AMERICA CORP /DE/ | $41.878.465 | 562.278 | 0,36% | Aktien |
| Cormorant Asset Management, LP | $40.964.000 | 550.000 | 0,36% | Aktien |
| GILDER GAGNON HOWE & CO LLC | $40.884.008 | 548.926 | 0,36% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $36.316.001 | 487.594 | 0,32% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $35.176.457 | 472.294 | 0,31% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $34.092.848 | 457.745 | 0,30% | Aktien |
| Catalio Capital Management, LP | $33.891.454 | 455.041 | 0,30% | Aktien |
| Bridgewater Associates, LP | $33.377.691 | 448.143 | 0,29% | Aktien |
| EVENTIDE ASSET MANAGEMENT, LLC | $32.557.442 | 437.130 | 0,28% | Aktien |
| Fisher Asset Management, LLC | $25.721.741 | 345.351 | 0,22% | Aktien |
| UBS Group AG | $25.687.705 | 344.894 | 0,22% | Aktien |
| BOONE CAPITAL MANAGEMENT LLC | $25.302.346 | 339.720 | 0,22% | Aktien |
| NOMURA HOLDINGS INC | $24.390.338 | 327.475 | 0,21% | Aktien |
| Weiss Asset Management LP | $23.847.304 | 320.184 | 0,21% | Aktien |
| Nicholas Investment Partners, LP | $23.200.073 | 311.494 | 0,20% | Aktien |
| Woodline Partners LP | $22.441.718 | 301.312 | 0,20% | Aktien |
| Candriam S.C.A. | $22.361.195 | 300.520 | 0,19% | Aktien |
| MACKENZIE FINANCIAL CORP | $22.227.811 | 298.440 | 0,19% | Aktien |
| Swiss National Bank | $21.941.808 | 294.600 | 0,19% | Aktien |
| CITADEL ADVISORS LLC | $21.278.936 | 285.700 | 0,19% | Kaufoption |
| CITADEL ADVISORS LLC | $20.943.776 | 281.200 | 0,18% | Verkaufsoption |
| Integral Health Asset Management, LLC | $20.482.000 | 275.000 | 0,18% | Aktien |
| NOMURA HOLDINGS INC | $19.811.680 | 266.000 | 0,17% | Kaufoption |
| PFM Health Sciences, LP | $18.870.104 | 253.358 | 0,16% | Aktien |
| FIRST TRUST ADVISORS LP | $18.451.526 | 247.738 | 0,16% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $18.273.370 | 245.346 | 0,16% | Aktien |
| MARSHALL WACE, LLP | $17.913.781 | 240.518 | 0,16% | Aktien |
| Caption Management, LLC | $17.726.240 | 238.000 | 0,15% | Kaufoption |
| Susquehanna Portfolio Strategies, LLC | $16.897.203 | 226.869 | 0,15% | Aktien |
| ExodusPoint Capital Management, LP | $16.752.563 | 224.927 | 0,15% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $16.565.618 | 222.417 | 0,14% | Aktien |
| NAN FUNG TRINITY (HK) LTD | $16.327.133 | 219.215 | 0,14% | Aktien |
| ROYCE & ASSOCIATES LP | $16.272.912 | 218.487 | 0,14% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $15.553.137 | 208.823 | 0,14% | Aktien |
| ALGERT GLOBAL LLC | $15.305.417 | 205.497 | 0,13% | Aktien |
| CITIGROUP INC | $14.598.080 | 196.000 | 0,13% | Verkaufsoption |
| California Public Employees Retirement System | $14.514.067 | 194.872 | 0,13% | Aktien |
| Longaeva Partners L.P. | $13.992.036 | 187.863 | 0,12% | Aktien |
| MIZUHO MARKETS AMERICAS LLC | $13.585.748 | 182.408 | 0,12% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $13.570.256 | 182.200 | 0,12% | Kaufoption |
| Cutter Capital Management, LP | $13.504.563 | 390.644 | 0,12% | Aktien |
| ADAR1 Capital Management, LLC | $13.159.797 | 176.689 | 0,11% | Aktien |
| BlackRock, Inc. | $12.997.803 | 174.514 | 0,11% | Aktien |
| RHUMBLINE ADVISERS | $12.750.043 | 171.188 | 0,11% | Aktien |
| ROYAL BANK OF CANADA | $12.654.000 | 169.892 | 0,11% | Aktien |
| Hillsdale Investment Management Inc. | $12.595.462 | 169.112 | 0,11% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $12.305.105 | 165.703 | 0,11% | Aktien |
| WCM INVESTMENT MANAGEMENT, LLC | $11.891.227 | 165.133 | 0,10% | Aktien |
Unternehmensinsider 25 Insider · 9 Führungskräfte · 16 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Neil Kumar | Chief Executive Officer | 16. August 2026 M | 278.307 | 0 | 4 | $-1.573.882 |
| Thomas Trimarchi | President and CFO | 16. August 2026 F | 336.529 | 0 | 3 | $-2.961.545 |
| Brian C Stephenson | CFO and Treasurer | 25. Februar 2025 M | 102.464 | 0 | 0 | $0 |
| Brian M. Stolz | Chief Operating Officer | 16. August 2020 M | 24.615 | 0 | 0 | $0 |
| Maricel Apuli | Chief Accounting Officer | 16. August 2026 F | 122.687 | 0 | 1 | $-160.120 |
| Cameron Turtle | Senior Vice President, Portfolio Management and Corporate Development | 28. Dezember 2020 M | 12.568 | 0 | 0 | $0 |
| Michael Thomas Henderson | Chief Business Officer | 15. Dezember 2020 A | 274.211 | 0 | 0 | $0 |
| Uma Sinha | Chief Scientific Officer | 15. Dezember 2020 A | 16.460 | 0 | 0 | $0 |
| Yi Ching Yau | Chief Accounting Officer | 16. November 2020 M | 4.586 | 0 | 0 | $0 |
| Andrea Ellis | Direktor | 9. Juli 2026 M | 22.579 | 0 | 1 | $-1.442.028 |
| Jennifer E. Cook | Direktor | 9. Juli 2026 M | 8.383 | 0 | 6 | $-21.920.848 |
| Hannah Valantine | Direktor | 22. Juni 2026 M | 9.259 | 0 | 2 | $-341.524 |
| Andrew Lo | Direktor | 22. Juni 2026 A | 18.079 | 0 | 0 | $0 |
| Douglas A. Dachille | Direktor | 22. Juni 2026 A | 10.579 | 0 | 0 | $0 |
| Ali J. Satvat | Direktor | 22. Juni 2026 A | 169.983 | 0 | 0 | $0 |
| Eric Aguiar | Direktor | 22. Juni 2026 A | 10.579 | 0 | 0 | $0 |
| Frank Mccormick | Direktor | 22. Juni 2026 A | 10.579 | 0 | 1 | $-3.933.840 |
| James C Momtazee | Direktor | 22. Juni 2026 A | 19.070 | 0 | 0 | $0 |
| Charles J Homcy | Direktor | 22. Juni 2026 A | 919.876 | 0 | 0 | $0 |
| DANIELS RONALD J | Direktor | 22. Juni 2026 A | 20.981 | 0 | 0 | $0 |
| Fred Hassan | Direktor | 22. Juni 2026 A | 29.879 | 0 | 0 | $0 |
| Randal W Scott | Direktor | 20. Juni 2025 A | 11.589 | 0 | 0 | $0 |
| Richard H Scheller | Direktor | 16. Februar 2023 M | 53.822 | 0 | 0 | $0 |
| Brent L Saunders | Direktor | 22. Juni 2022 A | 17.600 | 0 | 0 | $0 |
| BridgeBio Pharma, Inc. | 10%-Eigentümer | 26. Januar 2021 P | 1.000 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| KKR Genetic Disorder L.P., KKR Genetic Disorder GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×8 Einreichungen | 17. August 2026 | 4,70% | Änderung | Kapitalstruktur | SEC |
| VIKING GLOBAL INVESTORS LP, Viking Global Opportunities Parent GP LLC, Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, HALVORSEN OLE ANDREAS, Shabet Rose Sharon ×13 Einreichungen | 10. Juli 2026 | 5,00% | Änderung | — | SEC |
| Eidos Therapeutics, Inc. ×2 Einreichungen | 26. Januar 2021 | — | Erste Einreichung | — | SEC |
| BridgeBio Pharma, Inc. ×6 Einreichungen | 26. Januar 2021 | — | Erste Einreichung | — | SEC |
| BridgeBio Pharma LLC ×4 Einreichungen | 13. Dezember 2018 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 78 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| CANC · Tema ETF Trust | 2,75% | 73.191 NS | 31. Mai 2026 | N-PORT |
| HRTS · Tema ETF Trust | 2,59% | 20.327 NS | 31. Mai 2026 | N-PORT |
| BBP · ETFis Series Trust I | 1,51% | 12.592 NS | 30. April 2026 | N-PORT |
| SPIT · RBB Fund, Inc. | 1,37% | 5.527 NS | 30. April 2026 | N-PORT |
| LFSC · RBB Fund, Inc. | 1,17% | 18.534 NS | 31. Mai 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1,13% | 10.659 SH | 8. August 2026 | Täglich |
| JSML · Janus Detroit Street Trust | 1,11% | 49.222 NS | 30. April 2026 | N-PORT |
| IBB · iShares Trust | 1,08% | 1.241.499 SH | 8. August 2026 | Täglich |
| JSMD · Janus Detroit Street Trust | 1,06% | 145.924 NS | 30. April 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,93% | 68.003 NS | 30. April 2026 | N-PORT |
| ILDR · First Trust Exchange-Traded Fund VI… | 0,82% | 35.282 NS | 31. Mai 2026 | N-PORT |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 0,80% | 111.721 SH | 8. August 2026 | Täglich |
| GSC · Goldman Sachs ETF Trust | 0,73% | 27.974 NS | 31. Mai 2026 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 0,73% | 2.214 NS | 31. Mai 2026 | N-PORT |
| BIB · ProShares Trust | 0,64% | 7.167 NS | 31. Mai 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 0,62% | 3.028 NS | 31. Mai 2026 | N-PORT |
| FDMO · FIDELITY COVINGTON TRUST | 0,58% | 69.186 NS | 30. April 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,51% | 36.933 NS | 30. April 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,49% | 20.355 NS | 31. Mai 2026 | N-PORT |
| ISCG · iShares Trust | 0,43% | 51.606 SH | 8. August 2026 | Täglich |
| IQSM · New York Life Investments ETF Trust | 0,41% | 18.338 NS | 30. April 2026 | N-PORT |
| IWP · iShares Trust | 0,38% | 923.082 SH | 8. August 2026 | Täglich |
| SMLF · iShares Trust | 0,36% | 186.284 SH | 8. August 2026 | Täglich |
| VBK · VANGUARD INDEX FUNDS | 0,36% | 2.334.646 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,34% | 68.833 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,26% | 7.470 NS | 31. Mai 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,26% | 49.007 NS | 30. April 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,24% | 815.199 NS | 31. Mai 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0,23% | 20.342 NS | 30. April 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,23% | 77.319 NS | 30. April 2026 | N-PORT |
| IYH · iShares Trust | 0,23% | 101.091 SH | 8. August 2026 | Täglich |
| ISCB · iShares Trust | 0,21% | 7.345 SH | 8. August 2026 | Täglich |
| FTLS · First Trust Exchange-Traded Fund III | 0,21% | 68.022 NS | 30. April 2026 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0,21% | 459.045 NS | 31. Mai 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,20% | 56.781 NS | 30. April 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,19% | 28.343 NS | 31. Mai 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,19% | 50.525 SH | 8. August 2026 | Täglich |
| SMMD · iShares Trust | 0,19% | 84.760 SH | 8. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,17% | 66.688 NS | 30. April 2026 | N-PORT |
| ESML · iShares Trust | 0,17% | 57.771 SH | 8. August 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,16% | 4.042.835 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,16% | 441.129 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,16% | 5.841 NS | 31. Mai 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,15% | 10.157 NS | 30. April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,14% | 1.977.374 SH | 8. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,14% | 46.316 SH | 8. August 2026 | Täglich |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,12% | 179 NS | 31. Mai 2026 | N-PORT |
| WSML · iShares Trust | 0,11% | 9.054 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,11% | 5.909 NS | 31. Mai 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,11% | 11.025 SH | 8. August 2026 | Täglich |